ASNC says PET is now the preferred nuclear imaging test for CAD
The American Society of Nuclear Cardiology (ASNC) has shared its official answer to a decades-long debate over which cardiac nuclear...
Imaging
OSF HealthCare Partners to Enhance Mobile Imaging Services
OSF HealthCare and Shared Medical Services, Inc. (SMS) and are excited to announce the deployment of the mobile GE HealthCare...
GE HealthCare Enters an Agreement to Distribute Flyrcado Through CDL Nuclear Technologies Group, a Leading Provider of Cardiac PET Imaging Equipment and Services in the U.S.
GE HealthCare’s agreement with CardioNavix, a part of the CDL Nuclear Technologies services group, further broadens the reach of Flyrcado....
GE HealthCare Enters an Agreement to Distribute Flyrcado Through CDL Nuclear Technologies Group, a Leading Provider of Cardiac PET Imaging Equipment and Services in the U.S.
GE HealthCare’s agreement with CardioNavix, a part of the CDL Nuclear Technologies services group, further broadens the reach of Flyrcado....
FDA Approves Expanded Indications for GE HealthCare’s Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer’s Patients
PET brain scan using Vizamyl (flutemetamol F18) with quantification software The FDA has approved an updated label for Vizamyl (flutemetamol...
FDA broadens reach of GE HealthCare’s amyloid imaging agent Vizamyl in Alzheimer’s diagnostics
The FDA expanded the uses of GE HealthCare’s Vizamyl imaging agent for highlighting the presence of beta amyloid proteins in...
FDA Approves Expanded Indications for GE HealthCare’s Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer’s Patients |
ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--Jun 24, 2025--GE HealthCare (Nasdaq: GEHC) today announced that the U.S. Food and Drug Administration (FDA) has...
FDA Approves Expanded Indications for GE HealthCare’s Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer’s Patients
FDA Approves Expanded Indications for GE HealthCare’s Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for...
GE HealthCare Launches Revolutionary FDA-Approved Cardiac PET Imaging Agent
GE HealthCare (GEHC) has announced the U.S. launch of Flyrcado™, a groundbreaking positron emission tomography...
